AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

davis roger

 

Roger J. Davis Ph.D. F.R.S. is an Investigator of the Howard Hughes Medical Institute and is the H. Arthur Smith Chair in the Program in Molecular Medicine at the University of Massachusetts Medical School.  He also serves as Editor-in-Chief of the ASM journal Molecular & Cellular Biology.  The goal of research in the Davis laboratory is to understand mechanisms that mediate inflammation.  A primary focus is to understand the function of protein kinase signaling networks that promote inflammation, including the stress-activated MAP kinases.  These signaling pathways respond to the exposure to inflammatory agents (e.g. endotoxin) and mediate multiple biological responses.  The stress-activated MAP kinases are implicated in both innate and adaptive immune response and contribute to the development of inflammation-related diseases, including arthritis, cancer, diabetes, heart disease, and stroke.  The Davis laboratory is exploring the potential use of drugs to manipulate these signaling pathways for the treatment of human disease.


Visit: http://www.hhmi.org/research/investigators/davisrj.html

 

TPL_asm2013_SEARCH

91214